Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

VMD stock hub

Viemed Healthcare, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

VMDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

342.7M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

VMD

In the news

Latest news · VMD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.6

P25 12.6P50 18.3P75 33.7

Trailing P/E24.1

P25 15P50 23.3P75 38.5

ROE10.9

P25 -106.6P50 -46.9P75 -3.1

ROIC11.8

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All VMD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

240

Groups with data

Currency

USD

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001729149
Company name	Viemed Healthcare, Inc.
Country	United States
Country code	US
Cusip	92663R105
Employees	1,382
Employees Change	203%
Employees Change Percent	17.22
Enterprise value	$345.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Isin	CA92663R1055
Last refreshed	2026-05-10
Market cap	$342.7M
Market cap category	Small-Cap
Price	$8.94
Price currency	USD
Rev Per Employee	207,355.28x
Sector	Healthcare
Sic	8090
Symbol	VMD
Website	https://www.viemed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.34%
EV Earnings	23.2x
EV Sales Forward	1.08x
EV/EBIT	13.82x
EV/EBITDA	6.32x
EV/FCF	13.33x
EV/Sales	1.21x
FCF yield	7.56%
Forward P/E	18.63x
P/B ratio	2.39x
P/E ratio	24.1x
P/S ratio	1.2x
PE Ratio10 Y	25.12x
PE Ratio3 Y	27.56x
PE Ratio5 Y	29.18x
PS Forward	1.07x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.72%
EBITDA Margin	19.06%
FCF margin	9.04%
Gross margin	57.58%
Gross Profit	$165M
Gross Profit Growth	20.72%
Gross Profit Growth Q	28.69%
Gross Profit Growth3 Y	22.88%
Gross Profit Growth5 Y	14.93%
Net Income	$14.9M
Net Income Growth	21.19%
Net Income Growth Q	-1.64%
Net Income Growth Years	3%
Net Income Growth3 Y	35.56%
Net Income Growth5 Y	-12.46%
Pretax Margin	7.71%
Profit Margin	5.2%
Profit Per Employee	$10,775
Profitable Years	9
ROA	8.32
Roa5y	6.16
ROCE	15.96
ROE	10.89
Roe5y	9.37
ROIC	11.82
Roic5y	10.37

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	22.99%
Cagr3y	-5.81%
Cagr5y	-1.35%
EPS Growth	23.84
EPS Growth Years	3
EPS Growth3 Y	33.44
EPS Growth5 Y	-12.13
FCF Growth3 Y	51.31%
FCF Growth5 Y	-1.89%
OCF Growth	40.14%
OCF Growth Q	182.8%
OCF Growth3 Y	22.48%
OCF Growth5 Y	7.86%
Revenue Growth	23.1x
Revenue Growth Q	27.54x
Revenue Growth Quarters	18x
Revenue Growth Years	4x
Revenue Growth3 Y	25.17x
Revenue Growth5 Y	16.09x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.53
Assets	$197.4M
Cash	$9.8M
Current Assets	$49.8M
Current Liabilities	$40.7M
Debt	$12.4M
Debt EBITDA	$0.22
Debt Equity	$0.09
Debt FCF	$0.48
Equity	$145.8M
Interest Coverage	19.11
Liabilities	$51.6M
Long Term Assets	$147.6M
Long Term Liabilities	$10.9M
Net Cash	$-2.7M
Net Cash By Market Cap	$-0.78
Net Debt EBITDA	$0.05
Net Debt Equity	$0.02
Net Debt FCF	$0.1
Tangible Book Value	$83.7M
Tangible Book Value Per Share	$2.17
WACC	10.48

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.22
Inventory Turnover	25.08
Net Working Capital	$1.4M
Quick ratio	1.01
Working Capital	$9.1M
Working Capital Turnover	$25.21

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.28%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	22.97%
200-day SMA	7.65
3Y total return	-16.45%
50-day SMA	9.39
50-day SMA vs 200-day SMA	50over200
5Y total return	-6.58%
All Time High	12.01
All Time High Change	-25.56%
All Time High Date	2023-04-24
All Time Low	1.68
All Time Low Change	431.19%
All Time Low Date	2018-01-04
ATR	0.42
Beta	1.15
Beta1y	0.78
Beta2y	0.63
Ch YTD	20.32
High	9.16
High52	10.18
High52 Date	2026-05-01
High52ch	-12.18%
Low	8.85
Low52	5.93
Low52 Date	2025-08-01
Low52ch	50.76%
Ma50ch	-4.74%
Price vs 200-day SMA	16.88%
RSI	43.03
RSI Monthly	56.68
RSI Weekly	56.79
Sharpe ratio	0.62x
Sortino ratio	0.99
Total Return	1.28%
Tr YTD	20.32
Tr1m	-6.97%
Tr1w	-10.33%
Tr3m	3.47%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$0.09
Earnings EPS Estimate Growth	50
Earnings Revenue Estimate	74,520,000x
Earnings Revenue Estimate Growth	26.03x
Operating Income	$25M
Operating Income Growth	53.57
Operating Income Growth Q	203.3
Operating Income Growth3 Y	45.74
Operating Income Growth5 Y	5.82
Operating margin	8.72

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	30,289,807%
Float Percent	79.01%
Net Borrowing	5,109,000
Shares Insiders	13.72%
Shares Institutions	59.15%
Shares Out	38,336,802
Shares Qo Q	0.83%
Shares Yo Y	-1.28%
Short Float	1.16%
Short Ratio	1.07
Short Shares	0.92

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$16.6M
Average Volume	254,246.7x
Bv Per Share	3.73
CAPEX	$-31.2M
Ch1m	-6.97
Ch1w	-10.33
Ch1y	22.97
Ch3m	3.47
Ch3y	-16.45
Ch5y	-6.58
Ch6m	40.35
Change	-2.93%
Change From Open	-2.19
Close	9.21
Days Gap	-0.76
Depreciation Amortization	29,621,000
Dollar Volume	2,222,376.7
Earnings Date	2026-05-05
Earnings Time	amc
EBIT	$25M
EBITDA	$54.6M
EPS	$0.37
F Score	5
FCF	$25.9M
FCF EV Yield	7.5x
FCF Per Share	$0.68
Financing CF	-10,410,000
Fiscal Year End	December
Founded	2,006
Goodwill	58,938,000
Graham Number	5.58189
Graham Upside	-37.56
Income Tax	$6.7M
Investing CF	-47,121,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-04
Lynch Fair Value	$1.85
Lynch Upside	-79.26
Ma150	7.94
Ma150ch	12.57%
Ma20	9.58
Ma20ch	-6.63%
Net CF	-398,000
Next Earnings Date	2026-08-05
Open	9.14
Optionable	Yes
P FCF Ratio	13.22
P OCF Ratio	6
Position In Range	29.03
Ppne	79,308,000
Price Date	2026-05-08
Price EBITDA	$6.27
Ptbv Ratio	4.09
Relative Volume	0.98x
Revenue	286,565,000x
SBC By Revenue	3.24x
Share Based Comp	9,272,000
Tax By Revenue	2.34x
Tax Rate	30.4%
Tr6m	40.35%
Us State	Louisiana
Volume	248,588
Z Score	5.91

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does VMD pay a dividend?

Capital-return profile for this ticker.

Performance

VMD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns VMD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+59.2%

Float: +79.0% of shares outstanding

Insider ownership

+13.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

VMD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.0

Neutral momentum band

Price vs 200-day MA

+16.9%

50/200-day relationship not available

Beta (5Y)

1.15

Moves roughly with the market

Sharpe ratio

0.62

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About VMD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current VMD stock rating?

Viemed Healthcare, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full VMD analysis?

The full report lives at /stocks/VMD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for VMD?

The latest report frames VMD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the VMD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.